ImmunoPrecise Antibodies Ltd (IPA)
1.28
-0.02
(-1.54%)
USD |
NASDAQ |
May 07, 16:00
1.28
0.00 (0.00%)
After-Hours: 20:00
ImmunoPrecise Antibodies Cash from Operations (TTM): -3.051M for Jan. 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| January 31, 2024 | -3.051M |
| October 31, 2023 | -5.045M |
| July 31, 2023 | -7.432M |
| April 30, 2023 | -14.91M |
| January 31, 2023 | -14.54M |
| October 31, 2022 | -16.10M |
| July 31, 2022 | -15.13M |
| April 30, 2022 | -7.907M |
| January 31, 2022 | -6.979M |
| October 31, 2021 | -3.468M |
| July 31, 2021 | -1.542M |
| April 30, 2021 | -0.4585M |
| January 31, 2021 | 0.4691M |
| October 31, 2020 | 0.9691M |
| July 31, 2020 | -0.5604M |
| April 30, 2020 | -1.042M |
| January 31, 2020 | -2.096M |
| October 31, 2019 | -2.486M |
| July 31, 2019 | -2.494M |
| April 30, 2019 | -2.433M |
| January 31, 2019 | -2.364M |
| October 31, 2018 | -2.272M |
| July 31, 2018 | -1.894M |
| April 30, 2018 | -2.677M |
| January 31, 2018 |
| Date | Value |
|---|---|
| October 31, 2017 | |
| July 31, 2017 | |
| April 30, 2017 | |
| January 31, 2017 | |
| September 30, 2016 | -0.0167M |
| June 30, 2016 | -0.0017M |
| March 31, 2016 | -0.0007M |
| December 31, 2015 | -0.003M |
| September 30, 2015 | 0.0406M |
| June 30, 2015 | -0.0057M |
| March 31, 2015 | -0.0035M |
| December 31, 2014 | -0.0327M |
| September 30, 2014 | -0.3291M |
| June 30, 2014 | -0.1012M |
| March 31, 2014 | -0.0985M |
| December 31, 2013 | -0.1181M |
| September 30, 2013 | 0.1393M |
| June 30, 2013 | -0.0525M |
| March 31, 2013 | -0.0526M |
| December 31, 2012 | -0.0043M |
| September 30, 2012 | -0.1975M |
| June 30, 2012 | -0.1949M |
| March 31, 2012 | -0.2228M |
| December 31, 2011 | -0.1382M |
| September 30, 2011 | -4.979M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-16.10M
Minimum
Oct 2022
0.9691M
Maximum
Oct 2020
-5.463M
Average
-3.051M
Median
Jan 2024
Cash from Operations (TTM) Benchmarks
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -33.46M |
| Edesa Biotech Inc | -6.252M |
| Lexaria Bioscience Corp | -5.209M |
| Xenon Pharmaceuticals Inc | -145.33M |